Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis.
about
Low-dose rate brachytherapy for men with localized prostate cancerRadical prostatectomy versus watchful waiting for prostate cancerComparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancerAspirin improves outcome in high risk prostate cancer patients treated with radiation therapy.Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer.Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review.Impact of Age at Diagnosis on Outcomes in Men with Castrate-Resistant Prostate Cancer (CRPC).Watchful waiting and active surveillance: the current position.Antitumor effects of (32)P-chromic-poly (L-lactide) brachytherapy in nude mice with human prostate cancerTrends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000-2006.Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.Failure to address potential bias in non-randomised controlled clinical trials may cause lack of evidence on patient-reported outcomes: a method studyRacial Differences in Prostate Cancer Treatment: The Role of Socioeconomic Status.Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy.High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer.Are you now a good surgeon? T2 positive margin status as a quality outcome measure following radical prostatectomy.Brachytherapy improves outcomes in young men (≤60 years) with prostate cancer: A SEER analysis.Biochemical relapse-free survival in 400 patients treated with I-125 prostate brachytherapy: the Guildford experience.Major 30-day complications after radical radiotherapy: a population-based analysis and comparison with surgery.Preoperative characteristics of the P.R.O.S.T.A.T.E. scores: a novel predictive tool for the risk of positive surgical margin after radical prostatectomy.Meta-analysis of studies comparing oncologic outcomes of radical prostatectomy and brachytherapy for localized prostate cancer.Factors influencing prostate cancer patterns of care: An analysis of treatment variation using the SEER database.
P2860
Q24235544-F9B7A572-BBE3-4FF6-997E-5C87523DB4E9Q24236564-D3FF5508-C77C-478A-BA28-9D9BC8185DF8Q33679373-F18A0EDD-86C3-41A6-B8B4-CA270DF1B3ECQ33727848-33DE3C85-0DB9-4B1C-9B21-9BB477044826Q34795596-2BF5CD48-6473-49BE-B263-684C60C23D56Q35079338-65FF7EB5-B149-4BAC-95C1-E5DF8224F3EDQ36746831-5F2F893C-A650-47C3-9111-E6DFA117E295Q37142197-B1B344B7-2CD5-4375-877D-9BB394FEFCA3Q37211798-4084CE49-8849-4422-B3A3-483C0313E20AQ37457693-AF3B3E1A-1248-44AF-A3EC-FEC0CA8DA516Q37965553-6E6C53C2-317E-4BB5-BB54-A3624C1ACF5BQ38033742-F1E43A45-C5C6-4CA7-9134-7C0B8E07CF21Q38217667-BC31C849-1A7B-4624-8974-D4F798EE34A4Q38622917-3BE660B3-CCFF-4D03-8B5B-C05BDCEDAC85Q38790048-3592C9D4-E13F-44C5-8FBB-B6C3E79972B6Q38873431-3B4B51F4-3396-4953-A27D-A6C7BB20E132Q39823876-AF112ED3-F7E5-494F-A76D-D94E47E95B6DQ40358008-B2AB3980-9110-49FD-A3CE-98B996BC9988Q43576127-CAE71B43-70AA-43D5-9CDD-2D10870D9231Q44977818-F20D4DA3-5DB7-4C33-AF82-8A1FC82832D3Q47614644-1250A8FE-22B1-4587-93EE-B3C78FD23B16Q54949505-1F872AC4-018B-4C3D-A8A2-ECBBE22F718EQ55312114-6CEF822C-8F22-4D2B-9236-6418961767CE
P2860
Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Survival of men with clinicall ...... t: impact of age at diagnosis.
@en
Survival of men with clinicall ...... t: impact of age at diagnosis.
@nl
type
label
Survival of men with clinicall ...... t: impact of age at diagnosis.
@en
Survival of men with clinicall ...... t: impact of age at diagnosis.
@nl
prefLabel
Survival of men with clinicall ...... t: impact of age at diagnosis.
@en
Survival of men with clinicall ...... t: impact of age at diagnosis.
@nl
P2093
P356
P1433
P1476
Survival of men with clinicall ...... t: impact of age at diagnosis.
@en
P2093
Aniko Szabo
Christopher M Lee
David K Gaffney
Dennis C Shrieve
Jonathan D Tward
Lisa M Pappas
P2860
P304
P356
10.1002/CNCR.22261
P407
P577
2006-11-01T00:00:00Z